HARNESSING THE POWER OF IgE
  • Home
  • About Us
    • Company Overview
    • Management
    • Board of Directors
    • Scientific Founders
  • Technology
    • Why IgE?
    • IgE Platform Technology
    • Publications
  • Pipeline
  • News
    • News
    • Press Releases
  • Contact Us

HARNESSING THE POWER OF IgE
Close
  • Home
  • About Us
    • Company Overview
    • Management
    • Board of Directors
    • Scientific Founders
  • Technology
    • Why IgE?
    • IgE Platform Technology
    • Publications
  • Pipeline
  • News
    • News
    • Press Releases
  • Contact Us

Genetic Engineering News Article

Not to be Sneezed At

One of the stand-out technologies discussed by London-based immuno-oncology start-up IGEM Therapeutics was in antibody therapeutics…..

See the article in full here:  https://www.genengnews.com/gen-exclusives/biotrinity-conference-focuses-on-nextgen-healthcare/77901102

Recent Posts
IGEM Therapeutics appoints Dr David Chiswell as a Non-Executive Chairman
April 9, 2019by THIRTEEN581
IGEM Therapeutics announces further UK government funding to develop novel IgE antibody targeting solid tumours expressing HER2
April 2, 2019by THIRTEEN545
Categories
  • News
  • Press Releases

HARNESSING THE POWER OF IgE
UK-based Immuno-Oncology company focused on the development of IgE antibody drugs to fight cancer.
Contact Us
+44 (0)203 657 7612
  • General Enquiries
  • Interested in joining IGEM?
Menu
  • Home
  • About
  • Technology
  • Pipeline
IGEM Therapeutics Ltd © 2017 All Rights Reserved Terms of Use and Privacy Policy